|
시장보고서
상품코드
2053108
여드름 치료제 시장 : 치료법별, 투여 경로별, 지역별Acne Therapeutics Market, By Treatment and By Route of Administration, And By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
여드름 치료제 시장은 2026년에 74억 9,380만 달러로 추정되며, 2033년까지 101억 3,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 4.4%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 74억 9,380만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 4.40% | 2033년 시장 규모 예측: | 101억 3,000만 달러 |
여드름은 피부의 모공이 막혀서 발생하는 흔한 피부 질환으로, 모공이 막히면 블랙헤드, 화이트헤드, 여드름, 뾰루지 등이 발생합니다. 여드름은 전 세계 인구의 약 9.4%가 앓고 있으며, 전 세계적으로 가장 널리 퍼져 있는 질환 중 하나입니다. 이에 따라 안전하고 효과적인 여드름 치료제에 대한 수요가 증가하고 있습니다. 여드름 치료제에는 일반의약품인 크림, 젤, 세안제, 처방전이 필요한 항생제 등이 있습니다.
시장 역학
여드름 유병률 증가, 안전하고 효과적인 여드름 치료제에 대한 수요 증가, 연구 및 개발(R&D) 활성화, 여드름 제품 및 사용 가능한 치료법에 대한 사람들의 인식 증가는 예측 기간 동안 세계 여드름 치료제 시장의 성장을 촉진할 것으로 예상되는 주요 요인입니다.
예를 들어, 2022년 7월 STRATA Skin Sciences, Inc.는 면포성, 농포성, 염증성 심상성 여드름을 포함한 경증 및 중등도 여드름의 근본 원인을 표적으로 하는 비침습적 원내 치료 '테라클리어엑스(TheraClearX)'의 출시를 발표하였습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 기업의 주요 특징, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 여드름 치료제 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 여드름 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 여드름 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 여드름 치료제 시장 : 치료별, 2021-2033년
제5장 세계의 여드름 치료제 시장 : 투여 경로별, 2021-2033년
제6장 세계의 여드름 치료제 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSM 26.06.17Acne Therapeutics Market is estimated to be valued at USD 7,493.8 Mn in 2026 and is expected to reach USD 10,130.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7,493.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.40% | 2033 Value Projection: | USD 10,130 Mn |
Acne is the common skin condition where the pores of the skin clog, and pore blockages leads to blackheads, whiteheads, and/or pimples. Acne affect around 9.4% of the global population, making it one of the most prevalent disease worldwide. Hence, there is an increasing demand for safe and effective acne therapeutics. Acne therapeutics include over-the-counter creams, gels, and cleanser, as well as prescription antibiotics.
Market Dynamics
Increasing prevalence of acne, increasing demand for safe/effective acne therapeutics, increasing research and development (R&D), and growing awareness among people about acne products and available treatment options are some major factors expected to augment the growth of the global acne therapeutics market during the forecast period.
For instance, in July 2022, STRATA Skin Sciences, Inc. announced the launch of TheraClearX, a non-invasive, in-office acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular, and inflammatory acne vulgaris.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global acne therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Allergan, Ranbaxy, Bayer Ag, Johnson & Johnson, Nestle SA (Galderma), Glaxosmithkline Plc, Teva Pharmaceuticals, Cipher Pharmaceuticals, F. Hoffmann-la Roche Ltd., and Valeant Pharmaceuticals International Inc., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global acne therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acne therapeutics market.
Market Segmentation
- Global Acne Therapeutics Market, By Treatment (Revenue, USD Mn, 2021 - 2033)
- Therapeutics
- Retinoid
- Antibiotics
- Hormonal Agents, Combination Medications, Anti-inflammatory
- Other Agents
- Global Acne Therapeutics Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
- Oral
- Topical
- Others
- Global Acne Therapeutics Market, By Geography (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Allergan
- Ranbaxy
- Bayer Ag
- Johnson & Johnson
- Nestle SA (Galderma)
- Glaxosmithkline Plc
- Teva Pharmaceuticals
- Cipher Pharmaceuticals
- F.Hoffmann-la Roche Ltd.
- Valeant Pharmaceuticals International Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment
- Market Snapshot, By Route of Administration
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of acne
- Increasing demand for generics
- High demand for acne therapeutics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Acne Therapeutics Market, By Treatment, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Retinoid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Hormonal Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Combination Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Anti-inflammatory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Other Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
5. Global Acne Therapeutics Market, By Route of Administration, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Acne Therapeutics Market, By Geography, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- South Africa
- Israel
- GCC Countries
- Rest of the Middle East &Africa
7. Competitive Landscape
- Allergan
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ranbaxy
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nestle SA (Galderma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glaxosmithkline Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipher Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-la Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Valeant Pharmaceuticals International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
8. Section
- Research Methodology
- About us
